TIANYU PHARM
30070219.850.15% ( -0.03 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: TIANYU PHARM(300702) the Revenue is 811.67 M (+6.89%);the EBIT is 84.58 M (-28.14%);the EPS is 0.121 (-51.07%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.81B6.89%
----
----
EBIT
0.08B28.14%
----
----
EPS
0.121251.07%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf